【ChiCTR2100050586】Dr. Shon Shmushkevich, please upload the approved file of ethical committee. Association of disparity in insurance status with late survival in cardiac tumors: a multi-institutional cohort study from National Cancer Database
ChiCTR2100050586
正在进行
/
/
/
2021-08-31
/
/
Primary Malignant Cardiac Tumors
Dr. Shon Shmushkevich, please upload the approved file of ethical committee. Association of disparity in insurance status with late survival in cardiac tumors: a multi-institutional cohort study from National Cancer Database
Association of disparity in insurance status with late survival in cardiac tumors: a multi-institutional cohort study from National Cancer Database
The primary outcome will be late mortality differences among different insurance categories, while secondary outcomes included differences in treatment patterns, perioperative (30-day) mortality, and the trend of the annual proportion of each insurance category along the study period. Median follow up time will be assessed utilizing reversed Kaplan Meier curves.
连续入组
回顾性研究
The 2004-2017 National Cancer Database (NCDB) will be queried for patients with PMCTs.
N/A
Weill Cornell Medicine
/
1000
/
2021-08-02
2021-09-15
/
Primary malignant cardiac tumors (PMCTs)；
请登录查看N/a；
请登录查看Dr. Mohamed Rahouma
/
Dr. Mohamed Rahouma的其他临床试验
美国纽约威尔康乃尔医学院的其他临床试验
- Dr. Shon Shmushkevich, please upload the approved file of ethical committee. Association of disparity in insurance status with late survival in cardiac tumors: a multi-institutional cohort study from National Cancer Database
- Sex Differences in Primary Malignant Cardiac Tumors: A Multi-Institutional Study from National Cancer Database
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10